Europe Protein Chip Market Size, Share, and COVID-19 Impact Analysis, By Technology (Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays), By Application (Diagnostics, Proteomics, Protein Functional Analysis, Antibody Characterization), and Europe Protein Chip Market Insights, Industry Trends, Forecast to 2035

Europe Protein Chip Market Insights Forecasts to 2035

• The Europe Protein Chip Market Size Was Estimated at USD 1.05 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of Around 18.43% from 2025 to 2035
• The Europe Protein Chip Market Size is Expected to Reach USD 6.75 Billion by 2035

According to a research report published by Spherical Insights & Consulting, The Europe Protein Chip Market Size Is Anticipated To Reach USD 6.75 Billion By 2035, Growing At A CAGR Of 18.43% From 2025 To 2035. The market is driven by innovations are enhancing product efficiency, reducing operational costs, and expanding application capabilities across industries.

Market Overview

The protein chip market is a considerable portion of the market, influenced by increasing cancer cases and heavy investments in research and development in the biotech and pharma industries. A protein chip, or protein microarray, is an advanced and high-throughput laboratory instrument made up of a solid surface on which thousands of distinct proteins or capture molecules are fixed in a high-density, pre-defined pattern. Among the applications of these sophisticated chips are the detection of antigens and antibodies in blood samples, the discovery of disease-specific biomarkers, and the monitoring of disease progression or the evaluation of therapy in personalized medicine.

In July 2023, MYPROTEIN announced the release of limited-edition holiday-flavored protein crisps to attract consumers seeking healthier seasonal options. Their products are baked rather than fried, aligning with low-calorie, high-protein positioning.

The proactive government policies combined with financial incentives are the most important factors that drive the demand for gene therapy. Funding of the largest market share that was attributed to academic and research institutes in 2024 is generally directed towards the support of basic research, biomarker discovery and clinical studies. Germany has a strong position in the European market owing to the favorable state of the biotech industry and the large amount of research funding provided by the government.

Report Coverage

This research report categorizes the market for the Europe protein chip market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Europe protein chip market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Europe protein chip market.

Driving Factors

The protein chip market in Europe is driven by the growing occurrence of complicated and long-term illnesses, including cancer, heart and blood vessel diseases, and autoimmune disorders, which has resulted in creating a need for more advanced diagnostic tools, such as protein chips, with their capacity to support early detection and monitoring. The ongoing developments in protein chip technology, like enhanced sensitivity, specificity, and the joining of artificial intelligence (AI) and automation for data analysis, are not only increasing the workflow but also widening the range of areas where the technology can be applied.

Restraining Factors

The protein chip market in Europe is restrained by the manufacturing and analysis of protein chips entail the use of very advanced tools and software, which are very expensive, thus preventing the technology from being used by small and medium enterprises as well as research activities with limited resources. It is still very difficult to get a large quantity of active proteins of high quality and stability at once.

Market Segmentation

The Europe protein chip market share is categorised into technology and application.

• The analytical microarrays segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The Europe protein chip market is segmented by technology into analytical microarrays, functional protein microarrays, reverse phase protein microarrays. Among these, the analytical microarrays segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growth of the segment is driven by the use of high-throughput technologies in life sciences and related fields, which has resulted in widespread adoption and, consequently, such technologies are heavily relied upon in the development of proteins and assessment of their expression levels and affinities. Antibody microarrays are indispensable for these extensive profiling tasks. The large-scale screening of drugs and identification of therapeutic targets rely on the strong demand for high-throughput tools in the pharmaceutical and biotech industries, most notably in Germany, the UK, and France.

• The antibody characterization segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.  

Based on application, the Europe protein chip market is segmented into diagnostics, proteomics, protein functional analysis, antibody characterization. Among these, the antibody characterization segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The segmental growth is driven by the strong connection among major pharmaceutical and biotech companies that use protein chips as the main tools in making monoclonal antibodies and other targeted therapies. Protein chips play a crucial role in evaluating the antibody binding kinetics, class, and epitope specificity that are important in the new drug candidate validation process and also in guaranteeing that the new drugs have no cross-reactivity.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Europe protein chip market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies                                                                                               

• Agilent Technologies
• Thermo Fisher Scientific
• Illumina
• Roche Diagnostics
• Merck KGaA
• PerkinELmer
• BioRad Laboratories
• Danaher Corp
• Shimadzu Corp
• Quotient Ltd
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Europe, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Europe protein chip market based on the below-mentioned segments:

Europe Protein Chip Market, By Technology

• Analytical Microarrays
• Functional Protein Microarrays
• Reverse Phase Protein Microarrays

Europe Protein Chip Market, By Application

• Diagnostics
• Proteomics
• Protein Functional Analysis
• Antibody Characterization